Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative ranibizumab for persistent diabetic vitreous haemorrhage
2009-015559-25Phase 4Completed
- Sponsor
- King's College Hospital
- Start
- Mar 2010
- Modality
- Antibody Fragments → Engineered Antibody Formats → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ranibizumab in proliferative diabetic retinopathy (PDR) and Vitreous hemorrhage (VH) (2 arms), sponsored by King's College Hospital. Primary endpoint: Need for pars plana vitrectomy at week 7. Started Mar 2010; status: completed.
02
Drugs
ranibizumab
03
Conditions
proliferative diabetic retinopathy (PDR)Vitreous hemorrhage (VH)
Beyond the preview
Go deeper on 2009-015559-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-015559-25.